Aberdeen Labs

www.aberdeenlabs.com

Aberdeen Labs is listed in the VCMatch investor directory. Upload your deck to compare your startup against VCMatch's private fit signals for this investor.

Check Size

Not specified

Stages

Not specified

Focus Areas

Not specified

Geography

Not specified

Investment Thesis

Aberdeen Labs positions itself as a value-add technology investor that brings innovation to market by combining technology, advisory services, and capital. They partner selectively with high-potential startups and deploy a flexible set of engagement models (equity, options-for-services, and follow-on capital) to both build and scale companies.

Is Aberdeen Labs right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Aberdeen Labs is most relevant for founders raising venture-backed rounds in their stated focus areas.

Focus statement

Aberdeen Labs focuses on value-add technology investments in 'select high-potential startups' and uses technology, operational services, advisory capabilities, and capital to commercialize innovation and scale portfolio companies.

Value Add

Multiple partnership models: they explicitly offer three engagement models (Equity, Options, Capital) rather than a single funding approach, allowing flexibility to fit a startup's needs.
Service-for-equity approach: they provide technology and operational services in exchange for equity ('Aberdeen Labs takes an equity stake in the startup in exchange for technology and operational services').
Options-for-advisory-shares mechanism: they 'issue options for technology and operations services to startups which can be redeemed in exchange for advisory shares'—a non-standard structure that converts services into equity-based advisory compensation.
Follow-on capital for scaling: they will 'take an additional equity stake in a high performing portfolio company that needs a capital infusion to scale', indicating willingness to double down on winners.